FINWIRES · TerminalLIVE
FINWIRES

加拿大皇家银行称,博德里奇第三季度业绩超出预期,但交易延迟令其近期前景蒙上阴影。

By

-- 博德瑞金融解决方案公司 (BR) 公布的第三财季业绩超出华尔街预期,但加拿大皇家银行资本市场 (RBC Capital Markets) 周四发布的报告指出,成交速度放缓和交易时间延迟对近期前景构成压力。 RBC 表示,营收增长至 19.5 亿美元,调整后每股收益达到 2.72 美元,均高于预期。报告称,经常性收入增长 8%,这得益于股权和基金持仓的增加,从而提振了投资者沟通解决方案业务。 报告指出,成交额仅为 5750 万美元,同比下降 19%,原因是规模更大、更复杂的交易需要更长时间才能最终完成。RBC 还表示,博德瑞下调了全年成交额预期,但其在研项目仍比预期高出 20%。 报告称,博德瑞继续受益于稳定的经常性收入基础、在代理服务领域的领先地位以及代币化和数字化转型领域的新兴机遇。 RBC 将 Broadridge 股票的目标价格从 245 美元下调至 200 美元,以反映行业重新估值和近期压力,但维持其“跑赢大盘”评级。

Price: $155.31, Change: $+1.33, Percent Change: +0.86%

Related Articles

Research

Research Alert: CFRA Lowers View On Bio-rad Laboratories To Sell From Hold

CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We lower our 12-month price target by $45 to $235, reflecting a 25.6x multiple of our 2026 EPS estimate (down to $9.17 from $10.15; we cut our 2027 EPS estimate to $9.97 from $10.68), a discount to BIO's three-year historical forward average of 29.5x. Rather than a dramatic cut to National Institutes of Health (NIH) funding, Congress approved a modest increase for 2026 funding, helping reduce research budget concerns that loomed during 2025. However, BIO and peers anticipate that research spending growth from academic and early-stage biotech could remain muted over the near term as academic institutions adjust. The outlook for 2026 anticipates ongoing pressure, with BIO cutting sales and margin expectations during the Q1 earnings report, citing headwinds arising from the U.S.-Iran conflict in the Middle East such as weaker diagnostics sales and higher freight and fuel costs.

$BIO
Insider Trading

Comfort Systems USA Insider Sold Shares Worth $889,890, According to a Recent SEC Filing

Pablo G. Mercado, Director, on April 30, 2026, sold 500 shares in Comfort Systems USA (FIX) for $889,890. Following the Form 4 filing with the SEC, Mercado has control over a total of 3,000 common shares of the company, with 3,000 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1035983/000153524626000004/xslF345X05/form4-05012026_040501.xml

$FIX
Insider Trading

Kaiser Aluminum Insider Sold Shares Worth $524,757, According to a Recent SEC Filing

Keith Harvey, Director, President & CEO, on April 29, 2026, sold 3,031 shares in Kaiser Aluminum (KALU) for $524,757. Following the Form 4 filing with the SEC, Harvey has control over a total of 94,308 common shares of the company, with 94,308 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/811596/000119312526201545/xslF345X05/ownership.xml

$KALU